日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Expanding Horizons in Oncology: A Vision for ESMO Open

拓展肿瘤学视野:ESMO Open 的愿景

Liang, K; Feliciano, J L; Marrone, K A; Murray, J C; Hann, C L; Anagnostou, V; Tackett, S A; Shin, E J; Hales, R K; Voong, K R; Battafarano, R J; Yang, S C; Broderick, S R; Ha, J S; Forde, P M; Brahmer, J R; Lam, V K; Curigliano, G

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

切除的非小细胞肺癌新辅助抗PD-1治疗反应的病理特征:定量免疫相关病理反应标准(irPRC)的提议

Cottrell, T R; Thompson, E D; Forde, P M; Stein, J E; Duffield, A S; Anagnostou, V; Rekhtman, N; Anders, R A; Cuda, J D; Illei, P B; Gabrielson, E; Askin, F B; Niknafs, N; Smith, K N; Velez, M J; Sauter, J L; Isbell, J M; Jones, D R; Battafarano, R J; Yang, S C; Danilova, L; Wolchok, J D; Topalian, S L; Velculescu, V E; Pardoll, D M; Brahmer, J R; Hellmann, M D; Chaft, J E; Cimino-Mathews, A; Taube, J M

Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

食管癌新辅助治疗是否会增加术后发病率或死亡率?

Mungo, B; Molena, D; Stem, M; Yang, S C; Battafarano, R J; Brock, M V; Lidor, A O

The GPCR OGR1 (GPR68) mediates diverse signalling and contraction of airway smooth muscle in response to small reductions in extracellular pH.

GPCR OGR1 (GPR68) 介导多种信号传导,并能响应细胞外 pH 值的微小降低而引起气道平滑肌收缩

Saxena H, Deshpande D A, Tiegs B C, Yan H, Battafarano R J, Burrows W M, Damera G, Panettieri R A, Dubose T D Jr, An S S, Penn R B

Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms

抗内毒素单克隆抗体通过两种不同的机制抑制肿瘤坏死因子-α的分泌。

Burd, R S; Battafarano, R J; Cody, C S; Farber, M S; Ratz, C A; Dunn, D L